SRPT

Sarepta sees FY14 loss from operations $110M-$120M

moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]

Sarepta (SRPT) Enters Overbought Territory

moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against SAREPTA THERAPEUTICS, INC. and Its Board of Directors and a Lead Plaintiff Deadline of March 28, 2014 — SRPT

[GlobeNewswire] – NEW YORK — Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of Massachusetts on behalf of investors who purchased Sarepta … moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here […]

Trades are optimistic on Sarepta

moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]

Sarepta Therapeutics to Present Company Overview at the Cowen and Company 34th Annual Healthcare Conference

[Business Wire] – Sarepta Therapeutics , a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the Cowen and Company 34th Annual Healthcare Conference in Boston, MA on Tuesday, March 4, 2014 at 9:20 a.m. moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is […]

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Sarepta Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline — SRPT

[GlobeNewswire] – NEW YORK — Pomerantz LLP has filed a class action lawsuit against Sarepta Therapeutics, Inc. (Sarepta or the Company) and certain of its officers. The class action, filed in United … moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]

Sarepta Therapeutics to Announce Fourth Quarter and Full-Year 2013 Financial Results and Corporate Update on February 27, 2014

[Business Wire] – Sarepta Therapeutics, Inc. , a developer of innovative RNA-based therapeutics, will report fourth quarter and full-year 2013 financial results before the NASDAQ Global Market opens on Thursday, February 27, 2014. moreView todays social media effects on SRPTView the latest stocks trending across Twitter. Click to view dashboardSee who Sarepta is hiring next, click here to view […]